Home > Our commitment > Overview


Novartis has established a fully dedicated internal team, or coalition, to collaborate with top global experts  to examine root causes, risk factors, mitigation and potential treatment protocols for adverse events associated with Beovu.

The coalition is using agile collaboration, crowdsourcing communities and multidisciplinary expertise to generate and thoroughly investigate a broad range of hypotheses.

Novartis is fully committed to transparently communicating all facts and findings to ensure that ophthalmologists have the latest data and understanding they need to appropriately make treatment decisions for their patients.